Archive: 2025 / 08
The FTSE 100 Stock Outperforming Rolls-Royce in 2025: What Investors Need to Know
While Rolls-Royce often grabs the headlines, another FTSE 100 stock is quietly delivering returns that leave Rolls-Royce in the dust. Investors have started to notice this underrated gem as its share price soars past more popular blue-chips in 2025. Here’s what’s driving its surge and what it means for your portfolio.
Catherine’s Ordeal: The Hidden Struggles of Lyme Disease Diagnosis and Recovery
Catherine's experience reveals how Lyme disease can be misdiagnosed, especially without classic symptoms. After her complaints were dismissed as psychological, a second doctor found the infection with precise testing and started aggressive antibiotic therapy. Her slow but eventual recovery shows the complexity of diagnosing and treating Lyme disease.
